Nordea Bank on Friday upgraded the rating of Danish pharmaceutical company Novo Nordisk (NOVO-B.CO) to buy from hold.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)